Skip to main content
Clinical Trials/NCT06584981
NCT06584981
Completed
Not Applicable

Effect of PECS II, Parasternal and Serratus Plane Blocks on Postoperative Pain in MIDCAB Surgery

Hisar Intercontinental Hospital1 site in 1 country88 target enrollmentSeptember 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain, Postoperative
Sponsor
Hisar Intercontinental Hospital
Enrollment
88
Locations
1
Primary Endpoint
Analgesic efficiency
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

AIM: It was aimed to evaluate the effectiveness of pectoral nerve block (PECS II), parasternal and serratus plane blocks in postoperative analgesia in minimally invasive cardiac surgery (MIDCAB).

INTRODUCTION: The frequency of minimally invasive cardiac surgery has increased in recent years. With this method, Coronary artery bypass graft (CABG) operations can be performed without sternotomy. It is a beneficial method for early postoperative mobilization, early recovery and better aesthetic appearance. Since there is a surgical intervention between the ribs, pain control is important in these patients.

METHOD: In the preoperative evaluation of patients planned for CABG, PECS II, parasternal and serratus plane blocks are routinely recommended for postoperative pain control. Consent for the procedure is obtained from patients who accept this procedure. After induction and before the surgical incision, these block applications are performed under sterile conditions under the guidance of ultrasonography. Standard intravenous analgesic agents are applied to our patients who do not accept block applications. The hospital core system files of our patients who underwent cardiac surgery with minimally invasive intervention in our hospital between January 1, 2021 and December 31, 2021 will be scanned retrospectively. Patients with and without block application will be divided into two groups. From our patients' files; Demographic data, extubation time, drain site and incision site pain at the 1st, 2nd, 4th, 12th, 24th, 48th and 72nd hours after extubation will be noted. In addition, it will be noted whether there is a need for additional rescue analgesia in cases where block is performed. The data obtained will be evaluated statistically and the results will be published in national or international scientific journals.

Registry
clinicaltrials.gov
Start Date
September 1, 2024
End Date
June 30, 2025
Last Updated
4 months ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hasan Hüseyin KILIÇ

Hasan Huseyin Kilic

Hisar Intercontinental Hospital

Eligibility Criteria

Inclusion Criteria

  • Adult patients aged 18 and over
  • Patients who underwent MIDCAB surgery

Exclusion Criteria

  • Patients under 18 years of age
  • Patients who did not undergo MIDCAB surgery

Outcomes

Primary Outcomes

Analgesic efficiency

Time Frame: drain site and incision site pain at the 1st, 2nd, 4th, 12th, 24th, 48th and 72nd hours after extubation will be noted

Study Sites (1)

Loading locations...

Similar Trials